Literature DB >> 22582808

Sfrp5 expression and secretion in adipocytes are up-regulated during differentiation and are negatively correlated with insulin resistance.

Ci Lv1, Youzhao Jiang, Hui Wang, Bing Chen.   

Abstract

We have examined the patterns of Sfrp5 (secreted frizzled-related protein 5) mRNA expression and protein secretion during adipocyte differentiation, and investigated the potential role of Sfrp5 in IR (insulin resistance) in adipocytes. 3T3-L1 pre-adipocytes were induced for differentiation, and RT-PCR (reverse transcription-PCR) and ELISA assays were used to determine Sfrp5 mRNA expression and protein secretion. The results showed that with the differentiation and maturity of pre-adipocytes, transcription and protein secretion of Sfrp5 gradually increased, peaking on the 9th day of differentiation. Sfrp5 mRNA expression in mature adipocytes was decreased by 20, 22 and 32 upon treatment with dexamethasone, insulin and TNF (tumour necrosis factor) respectively, whereas Sfrp5 protein secretion was decreased by 15, 17 and 30%, correspondingly. In contrast, Sfrp5 mRNA expression in mature adipose was increased by 34 and 19% upon treatment with rosiglitazone and metformin respectively, whereas Sfrp5 protein secretion was increased by 10 and 6%, correspondingly. In conclusion, Sfrp5 mRNA expression and protein secretion depend on the differentiation of adipocytes. The dysregulation of Sfrp5 expression and secretion is directly correlated with IR. Up-regulation of Sfrp5 expression and secretion in adipocytes may be one crucial mechanism by which rosiglitazone and metformin improve insulin sensitivity. © The Author(s) Journal compilation
© 2012 International Federation for Cell Biology.

Entities:  

Keywords:  3T3-L1 pre-adipocytes; Sfrp5; adipogenesis; insulin resistance; obese

Mesh:

Substances:

Year:  2012        PMID: 22582808     DOI: 10.1042/CBI20120054

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  14 in total

1.  Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat.

Authors:  Sandra A Rebuffat; Joana M Oliveira; Jordi Altirriba; Nuria Palau; Ainhoa Garcia; Yaiza Esteban; Belen Nadal; Ramon Gomis
Journal:  Diabetologia       Date:  2013-09-05       Impact factor: 10.122

2.  Adipocyte-derived SFRP5 inhibits breast cancer cells migration and invasion through Wnt and epithelial-mesenchymal transition signaling pathways.

Authors:  Wenzhong Zhou; Chunmiao Ye; Liang Li; Liyuan Liu; Fei Wang; Lixiang Yu; Fei Zhou; Yujuan Xiang; Yongjiu Wang; Gengshen Yin; Zhongbing Ma; Qinye Fu; Qiang Zhang; Dezong Gao; Shuya Huang; Zhigang Yu
Journal:  Chin J Cancer Res       Date:  2020-06       Impact factor: 5.087

3.  Common genetic variation in sFRP5 is associated with fat distribution in men.

Authors:  J K Van Camp; S Beckers; D Zegers; A Verrijken; L F Van Gaal; W Van Hul
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

4.  Nucleotide variation of sFRP5 gene is not associated with obesity in children and adolescents.

Authors:  Jasmijn K Van Camp; Sigri Beckers; Doreen Zegers; Stijn L Verhulst; Kim Van Hoorenbeeck; Guy Massa; An Verrijken; Kristine N Desager; Luc F Van Gaal; Wim Van Hul
Journal:  Mol Biol Rep       Date:  2016-08-06       Impact factor: 2.316

5.  Demethylation of SFRP2 by histone demethylase KDM2A regulated osteo-/dentinogenic differentiation of stem cells of the apical papilla.

Authors:  Guoxia Yu; Jinsong Wang; Xiao Lin; Shu Diao; Yu Cao; Rui Dong; Liping Wang; Songlin Wang; Zhipeng Fan
Journal:  Cell Prolif       Date:  2016-04-13       Impact factor: 6.831

6.  The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis.

Authors:  Hongyun Wang; Fengxia Li; Jing Feng; Junping Wang; Xiaobing Liu
Journal:  Ann Transl Med       Date:  2021-04

7.  Declined plasma sfrp5 concentration in patients with type 2 diabetes and latent autoimmune diabetes in adults.

Authors:  Liqing Cheng; Dongmei Zhang; Bing Chen
Journal:  Pak J Med Sci       Date:  2015       Impact factor: 1.088

8.  Dual Effects of Metformin on Adipogenic Differentiation of 3T3-L1 Preadipocyte in AMPK-Dependent and Independent Manners.

Authors:  Dian Chen; Ying Wang; Kaikai Wu; Xingya Wang
Journal:  Int J Mol Sci       Date:  2018-05-23       Impact factor: 5.923

Review 9.  Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease.

Authors:  Shan Tong; Qingwei Ji; Yu Du; Xiaogang Zhu; Caizhong Zhu; Yujie Zhou
Journal:  J Interferon Cytokine Res       Date:  2019-06-13       Impact factor: 2.607

Review 10.  Research update on the association between SFRP5, an anti-inflammatory adipokine, with obesity, type 2 diabetes mellitus and coronary heart disease.

Authors:  Di Wang; Yaping Zhang; Chengxing Shen
Journal:  J Cell Mol Med       Date:  2020-01-31       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.